These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27429855)

  • 21. TNFα-induced Up-regulation of
    Liu Z; Wang X; Jiang K; Ji X; Zhang YA; Chen Z
    Aging Dis; 2019 Dec; 10(6):1207-1220. PubMed ID: 31788333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2.
    Zeng C; Qi G; Shen Y; Li W; Zhu Q; Yang C; Deng J; Lu W; Liu Q; Jin J
    Cancer Med; 2023 Jan; 12(1):412-424. PubMed ID: 35670012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
    Chu Y; Hu X; Wang G; Wang Z; Wang Y
    Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma.
    Chao L; Liu J; Zhao D
    Oncol Lett; 2017 May; 13(5):2891-2896. PubMed ID: 28521394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma.
    Xu K; Xiong W; Zhao S; Wang B
    Oncol Lett; 2019 Sep; 18(3):3342-3348. PubMed ID: 31452813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
    Ju L; Zhou YM; Yang GS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
    Shi X; Guan X
    Diagn Pathol; 2019 Oct; 14(1):117. PubMed ID: 31651329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
    Tang J; Zhao H; Cai H; Wu H
    Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of G Protein-coupled Receptor 56 Is an Unfavorable Prognostic Factor in Osteosarcoma Patients.
    Chen Z; Gao P; Li Z
    Tohoku J Exp Med; 2016 Jul; 239(3):203-11. PubMed ID: 27396430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
    Li Z; Jia M; Wu X; Cui J; Pan A; Li L
    Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
    Liu Y; Sun X; Huo C; Sun C; Zhu J
    Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.